CORCEPT THERAPEUTICS INC Quarterly Weighted Average Number of Shares Outstanding, Diluted from Q2 2015 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Corcept Therapeutics Inc quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q2 2015 to Q3 2024.
  • Corcept Therapeutics Inc Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2024 was 114M shares, a 2.36% increase year-over-year.
  • Corcept Therapeutics Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 112M shares, a 3.64% decline from 2022.
  • Corcept Therapeutics Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 116M shares, a 7.94% decline from 2021.
  • Corcept Therapeutics Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 126M shares, a 1.42% increase from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 114M +2.62M +2.36% Jul 1, 2024 Sep 30, 2024 10-Q 2024-10-30
Q2 2024 111M +1.65M +1.51% Apr 1, 2024 Jun 30, 2024 10-Q 2024-07-29
Q1 2024 110M -5.51M -4.77% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-01
Q4 2023 112M -4.22M -3.64% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-15
Q3 2023 111M -5.52M -4.73% Jul 1, 2023 Sep 30, 2023 10-Q 2024-10-30
Q2 2023 110M -5.81M -5.03% Apr 1, 2023 Jun 30, 2023 10-Q 2024-07-29
Q1 2023 115M +388K +0.34% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-01
Q4 2022 116M -10M -7.94% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-15
Q3 2022 117M -8.52M -6.81% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-01
Q2 2022 115M -11.3M -8.91% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-02
Q1 2022 115M -14.6M -11.3% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-03
Q4 2021 126M +1.77M +1.42% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-15
Q3 2021 125M +672K +0.54% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 127M +3.45M +2.8% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 130M +7.44M +6.09% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 124M +1.63M +1.33% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-28
Q3 2020 124M +2.7M +2.22% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-03
Q2 2020 123M +1.45M +1.19% Apr 1, 2020 Jun 30, 2020 10-Q 2021-07-29
Q1 2020 122M -1.67M -1.35% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 123M -4.12M -3.25% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-15
Q3 2019 122M -4.4M -3.49% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-03
Q2 2019 122M -5.73M -4.5% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-04
Q1 2019 124M -3.84M -3.01% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-04
Q4 2018 127M +2.17M +1.75% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-23
Q3 2018 126M +508K +0.4% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q2 2018 128M +4.5M +3.66% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-01
Q1 2018 128M +6.54M +5.4% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q4 2017 125M +8.38M +7.21% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-24
Q3 2017 126M +9.23M +7.93% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-02
Q2 2017 123M +7.68M +6.66% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 121M +11.5M +10.5% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-09
Q4 2016 116M Oct 1, 2016 Dec 31, 2016 10-K 2019-02-26
Q3 2016 116M +7.96M +7.34% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-03
Q2 2016 115M +7.46M +6.91% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-02
Q1 2016 110M Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-02
Q3 2015 108M Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-02
Q2 2015 108M Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.